SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on new 24-month HOPE-3 open-label extension data for deramiocel, which traders view as supportive of sustained slowing in upper-limb decline and relevant to the FDAs review. Many are bullish on approval prospects, while skeptics question how persuasive the open-label results are and whether disputes over the trials statistical analysis plan will affect the decision.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhoods summit announcementsespecially planned 24/7 stock trading and expanded tools such as Robinhood Social and longer options hoursare driving discussion. Traders welcome the product expansion but debate whether it will translate into lasting momentum, with some frustrated by the stocks difficulty holding gains.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns fiscal fourth-quarter earnings and guidance are the main focus, with traders looking for confirmation that AI-driven memory demand, tight DRAM and NAND supply, and pricing strength can persist. Bullish expectations for strong results compete with concerns that optimism is already priced in and the stock could sell off on the news, especially if managements outlook raises doubts about the memory cycles duration.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desks steep slide to multi-year lows is driving discussion, with traders citing slowing growth, concerns about advertising demand and competition from Amazon and other platforms. Many criticize management and fear further losses, while some argue the cash-rich, profitable business is oversold and could rebound if growth improves.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances shares surged after the company raised its full-year revenue outlook, citing stronger demand for Amtagvi and Proleukin; analyst upgrades added to the bullish reaction. Traders are debating whether the high-volume rally reflects short covering or may give way to profit-taking, while many are also watching for upcoming lung-cancer data.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

A pause in the marijuana rescheduling hearing after opponents raised a GAO report on gaps in federal drug-scheduling procedures has heightened uncertainty around the path to Schedule III. Traders are divided between fearing another prolonged delay and viewing the selloff as an overreaction to a procedural issue, with some buying the dip.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

A 737 MAX software glitch and the FAAs resulting delay to MAX 10 certification are dominating discussion, with traders concerned about delivery timing and Boeings regulatory credibility. Bulls argue the issue is manageable and the selloff is overdone, while skeptics point to Boeings recurring quality and certification setbacks.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FICO shares plunged after the FHFA moved to put VantageScore on the same mortgage-pricing grid as FICO, with Rocket Mortgage also signaling plans to favor the rival model for eligible loans. Traders fear increased competition could erode FICOs mortgage-scoring market share and pricing power, while some argue the selloff overstates the threat because FICO remains established in lending and its business is still growing.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vandas reported positive Phase 3 results for HETLIOZ in delayed sleep-wake phase disorder are driving attention, with traders welcoming the trial outcome while some question the commercial prospects given generic competition. The broader discussion also reflects skepticism about the companys execution and the stocks ability to sustain gains.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

Rising Treasury yields and expectations for further Fed rate hikes, alongside oil-price and geopolitical inflation concerns, are weighing on the Dow and broader equities. Traders are split between warning of a deeper pullback and viewing the weakness as a buying opportunity, with some pointing to market resilience.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


TerribleInvestor22

Neil